BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15050968)

  • 1. Mammalian N-acetylglutamate synthase.
    Morizono H; Caldovic L; Shi D; Tuchman M
    Mol Genet Metab; 2004 Apr; 81 Suppl 1(Suppl 1):S4-11. PubMed ID: 15050968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, cloning and expression of the mouse N-acetylglutamate synthase gene.
    Caldovic L; Morizono H; Yu X; Thompson M; Shi D; Gallegos R; Allewell NM; Malamy MH; Tuchman M
    Biochem J; 2002 Jun; 364(Pt 3):825-31. PubMed ID: 12049647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of the human N-acetylglutamate synthase gene.
    Caldovic L; Morizono H; Gracia Panglao M; Gallegos R; Yu X; Shi D; Malamy MH; Allewell NM; Tuchman M
    Biochem Biophys Res Commun; 2002 Dec; 299(4):581-6. PubMed ID: 12459178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inversion of allosteric effect of arginine on N-acetylglutamate synthase, a molecular marker for evolution of tetrapods.
    Haskins N; Panglao M; Qu Q; Majumdar H; Cabrera-Luque J; Morizono H; Tuchman M; Caldovic L
    BMC Biochem; 2008 Sep; 9():24. PubMed ID: 18801197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel mutations of the human N-acetylglutamate synthase gene and their functional investigation by expression studies.
    Schmidt E; Nuoffer JM; Häberle J; Pauli S; Guffon N; Vianey-Saban C; Wermuth B; Koch HG
    Biochim Biophys Acta; 2005 Apr; 1740(1):54-9. PubMed ID: 15878741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy.
    Elpeleg O; Shaag A; Ben-Shalom E; Schmid T; Bachmann C
    Ann Neurol; 2002 Dec; 52(6):845-9. PubMed ID: 12447942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations and polymorphisms in the human N-acetylglutamate synthase (NAGS) gene.
    Caldovic L; Morizono H; Tuchman M
    Hum Mutat; 2007 Aug; 28(8):754-9. PubMed ID: 17421020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis in patients with N-acetylglutamate synthase deficiency.
    Häberle J; Schmidt E; Pauli S; Kreuder JG; Plecko B; Galler A; Wermuth B; Harms E; Koch HG
    Hum Mutat; 2003 Jun; 21(6):593-7. PubMed ID: 12754705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel bifunctional N-acetylglutamate synthase-kinase from Xanthomonas campestris that is closely related to mammalian N-acetylglutamate synthase.
    Qu Q; Morizono H; Shi D; Tuchman M; Caldovic L
    BMC Biochem; 2007 Apr; 8():4. PubMed ID: 17425781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia.
    Caldovic L; Morizono H; Panglao MG; Cheng SF; Packman S; Tuchman M
    Hum Genet; 2003 Apr; 112(4):364-8. PubMed ID: 12594532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue.
    Dercksen M; Duran M; IJlst L; Kulik W; Ruiter JP; van Cruchten A; Tuchman M; Wanders RJ
    Mol Genet Metab; 2016 Dec; 119(4):307-310. PubMed ID: 27771289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical properties of recombinant human and mouse N-acetylglutamate synthase.
    Caldovic L; Lopez GY; Haskins N; Panglao M; Shi D; Morizono H; Tuchman M
    Mol Genet Metab; 2006 Mar; 87(3):226-32. PubMed ID: 16321554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic analysis of an unusual gene-enzyme relationship in the arginine biosynthetic pathway among marine gamma proteobacteria: implications concerning the formation of N-acetylated intermediates in prokaryotes.
    Xu Y; Glansdorff N; Labedan B
    BMC Genomics; 2006 Jan; 7():4. PubMed ID: 16409639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylglutamate synthase: structure, function and defects.
    Caldovic L; Ah Mew N; Shi D; Morizono H; Yudkoff M; Tuchman M
    Mol Genet Metab; 2010; 100 Suppl 1(Suppl 1):S13-9. PubMed ID: 20303810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles.
    Caldovic L; Morizono H; Panglao MG; Lopez GY; Shi D; Summar ML; Tuchman M
    Hum Mutat; 2005 Mar; 25(3):293-8. PubMed ID: 15714518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
    Sonaimuthu P; Senkevitch E; Haskins N; Uapinyoying P; McNutt M; Morizono H; Tuchman M; Caldovic L
    Sci Rep; 2021 Feb; 11(1):3580. PubMed ID: 33574402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylglutamate and its changing role through evolution.
    Caldovic L; Tuchman M
    Biochem J; 2003 Jun; 372(Pt 2):279-90. PubMed ID: 12633501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.
    Häberle J; Moore MB; Haskins N; Rüfenacht V; Rokicki D; Rubio-Gozalbo E; Tuchman M; Longo N; Yandell M; Andrews A; AhMew N; Caldovic L
    Hum Mutat; 2021 Dec; 42(12):1624-1636. PubMed ID: 34510628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
    Kenneson A; Singh RH
    Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.
    Ah Mew N; Caldovic L
    Appl Clin Genet; 2011; 4():127-35. PubMed ID: 23776373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.